Garrison Point Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$211K	Hold	9,501	–	–	0.1%	161
2025 Q4	$254K	Sell	9,501 -1,075	-10%	-$25.7K	0.11%	147
2025 Q3	$226K	Hold	10,576	–	–	0.09%	160
2025 Q2	$228K	Hold	10,576	–	–	0.1%	158
2025 Q1	$176K	Hold	10,576	–	–	0.09%	159
2024 Q4	$194K	Hold	10,576	–	–	0.09%	159
2024 Q3	$163K	Buy	+10,576	New	+$176K	0.1%	144
2024 Q2	–	Sell	-10,020	Closed	-$185K	–	144
2024 Q1	$185K	Hold	10,020	–	–	0.12%	148
2023 Q4	$314K	Hold	10,020	–	–	0.22%	112
2023 Q3	$209K	Hold	10,020	–	–	0.16%	139
2023 Q2	$240K	Sell	10,020 -250	-2%	-$5.56K	0.17%	137
2023 Q1	$193K	Hold	10,270	–	–	0.15%	154
2022 Q4	$163K	Hold	10,270	–	–	0.13%	139
2022 Q3	$168K	Hold	10,270	–	–	0.15%	137
2022 Q2	$145K	Buy	10,270 +50	+0.5%	+$933	0.12%	146
2022 Q1	$248K	Hold	10,220	–	–	0.17%	134
2021 Q4	$239K	Buy	+10,220	New	+$206K	0.16%	141
2021 Q1	–	Sell	-4,525	Closed	-$242K	–	142
2020 Q4	$242K	Buy	+4,525	New	+$225K	0.19%	123
2020 Q3	–	Sell	-4,525	Closed	-$219K	–	130
2020 Q2	$219K	Sell	4,525 -250	-5%	-$12K	0.22%	116
2020 Q1	$202K	Sell	4,775 -1,352	-22%	-$55.7K	0.25%	106
2019 Q4	$262K	Hold	6,127	–	–	0.24%	109
2019 Q3	$221K	Buy	+6,127	New	+$186K	0.22%	115